In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy

Paul A. Foster; Simon P. Newman; Surindaer. K. Chander; Chloe Stengel; Roma Jhalli; Lawrence L. W. Woo; Barry V. L. Potter; Michael  J. Reed; Atul Purohit

doi:10.1158/1078-0432.CCR-06-0632

In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy

Paul A. Foster, Simon P. Newman, Surindaer. K. Chander, Chloe Stengel, Roma Jhalli, Lawrence L. W. Woo, Barry V. L. Potter, Michael J. Reed, Atul Purohit

Department of Life Sciences

Research output: Contribution to journal › Article › peer-review

59 Citations (SciVal)

Original language	English
Pages (from-to)	5543-5549
Journal	Clinical Cancer Research
Volume	12
Issue number	18
DOIs	https://doi.org/10.1158/1078-0432.CCR-06-0632
Publication status	Published - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/1078-0432.CCR-06-0632

Cite this

@article{b0678a01f24342ef9c35e3654811a517,

title = "In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy",

author = "Foster, {Paul A.} and Newman, {Simon P.} and Chander, {Surindaer. K.} and Chloe Stengel and Roma Jhalli and Woo, {Lawrence L. W.} and Potter, {Barry V. L.} and Reed, {Michael J.} and Atul Purohit",

year = "2006",

doi = "10.1158/1078-0432.CCR-06-0632",

language = "English",

volume = "12",

pages = "5543--5549",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "18",

}

TY - JOUR

T1 - In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy

AU - Foster, Paul A.

AU - Newman, Simon P.

AU - Chander, Surindaer. K.

AU - Stengel, Chloe

AU - Jhalli, Roma

AU - Woo, Lawrence L. W.

AU - Potter, Barry V. L.

AU - Reed, Michael J.

AU - Purohit, Atul

PY - 2006

Y1 - 2006

UR - http://dx.doi.org/10.1158/1078-0432.CCR-06-0632

U2 - 10.1158/1078-0432.CCR-06-0632

DO - 10.1158/1078-0432.CCR-06-0632

M3 - Article

SN - 1078-0432

VL - 12

SP - 5543

EP - 5549

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 18

ER -

In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy

UN SDGs

Access to Document

Other files and links

Cite this